Exosomes in neurologic and psychiatric disorders
Abstract
Purposes The purposes of this review were to discuss the role of exosomes in neurologic and psychiatric diseases and to propose future therapeutic approaches.Methods PubMed was searched (2000-2014) using the terms exosomes, microvesicles, neurological disorders, psychiatric disorders, multivesicular bodies, Alzheimer's disease, Parkinson's disease, prion disease, multiple sclerosis, schizophrenia, glioblastoma multiforme, and flavonoids.Findings Many cells of the nervous system have been reported to release exosomes that could have an active role in the function, development, and diseases of the CNS, such as Alzheimer disease, Parkinson disease, prion diseases, multiple sclerosis, brain tumors, and schizophrenia. In all of these diseases, exosomes are involved in the spread of "toxic" proteins that are mutated or "misfolded" and serve as templates for the formation of disease-producing oligomers.Implications Exosomes' simple structure and abilities to be incorporated into plasma membrane and to cross the blood-brain barrier allow for the opportunity to utilize them as delivery vehicles of drugs and genetic elements in the treatment of immune, psychiatric, and neurologic disorders. Flavonoids have emerged as unique, natural molecules with antioxidant and antiinflammatory properties. It would, therefore, be of interest to design flavonoid-containing exosomes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Exosomes can carry specific miRNAs to cell receptors and play a key role in the pathogenesis of central nervous system diseases.
“Exosomes, which are considered as delivery vectors, can carry specific miRNAs to cell receptors, and play a key role in the pathogenesis of central nervous system diseases.36”
From Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression (2022) · cites this paper as [36]
The citation lists haven’t been fetched yet
References 65 · Cited by 93
- Authors
- Tsilioni, I., Panagiotidou, S., & Theoharides, T. C.
- Affiliations
- Tufts University (US)
- Corresponding author
- Theoharides, Theoharis C.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 36
- Issue
- 6
- Pages
- 882-888
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2133972920
- Cited by
- 93
- References
- 65
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 10 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 7 · 2015: 13 · 2014: 5
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- exosomes, microvesicles, neurological disorders, mental illness, Alzheimer's disease, Parkinson's disease, prion disease, multiple sclerosis, schizophrenia, glioblastoma, protein oligomerization, blood-brain barrier, drug carriers, flavonoids, multivesicular bodies
- MeSH terms
- Alzheimer Disease, Blood-Brain Barrier, Central Nervous System Diseases, Humans, Multiple Sclerosis, Parkinson Disease, Schizophrenia, Prion Diseases, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review